Mostrar el registro sencillo del ítem
dc.contributor.author
Oortwijn, Wija
dc.contributor.author
Husereau, Don
dc.contributor.author
Abelson, Julia
dc.contributor.author
Barasa, Edwine
dc.contributor.author
Bayani, Diana
dc.contributor.author
Canuto Santos, Vania
dc.contributor.author
Culyer, Anthony
dc.contributor.author
Facey, Karen
dc.contributor.author
Grainger, David
dc.contributor.author
Kieslich, Katharina
dc.contributor.author
Ollendorf, Daniel
dc.contributor.author
Pichón-riviere, Andres
dc.contributor.author
Sandman, Lars
dc.contributor.author
Strammiello, Valentina
dc.contributor.author
Teerawattananon, Yot
dc.date.available
2023-11-09T13:19:49Z
dc.date.issued
2022-06
dc.identifier.citation
Oortwijn, Wija; Husereau, Don; Abelson, Julia; Barasa, Edwine; Bayani, Diana; et al.; Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force; Elsevier; Value In Health; 25; 6; 6-2022; 869-886
dc.identifier.issn
1098-3015
dc.identifier.uri
http://hdl.handle.net/11336/217642
dc.description.abstract
Objectives: Deliberative processes for health technology assessment (HTA) are intended to facilitate participatory decision making, using discussion and open dialogue between stakeholders. Increasing attention is being given to deliberative processes, but guidance is lacking for those who wish to design or use them. Health Technology Assessment International (HTAi) and ISPOR—The Professional Society for Health Economics and Outcomes Research initiated a joint Task Force to address this gap. Methods: The joint Task Force consisted of 15 members with different backgrounds, perspectives, and expertise relevant to the field. It developed guidance and a checklist for deliberative processes for HTA. The guidance builds upon the few, existing initiatives in the field, as well as input from the HTA community following an established consultation plan. In addition, the guidance was subject to 2 rounds of peer review. Results: A deliberative process for HTA consists of procedures, activities, and events that support the informed and critical examination of an issue and the weighing of arguments and evidence to guide a subsequent decision. Guidance and an accompanying checklist are provided for (i) developing the governance and structure of an HTA program and (ii) informing how the various stages of an HTA process might be managed using deliberation. Conclusions: The guidance and the checklist contain a series of questions, grouped by 6 phases of a model deliberative process. They are offered as practical tools for those wishing to establish or improve deliberative processes for HTA that are fit for local contexts. The tools can also be used for independent scrutiny of deliberative processes.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
DELIBERATIVE PROCESSES
dc.subject
GUIDANCE
dc.subject
HEALTH TECHNOLOGY ASSESSMENT
dc.subject
PARTICIPATION
dc.subject
STAKEHOLDERS
dc.subject.classification
Políticas y Servicios de Salud
dc.subject.classification
Ciencias de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2023-11-06T15:28:34Z
dc.journal.volume
25
dc.journal.number
6
dc.journal.pagination
869-886
dc.journal.pais
Países Bajos
dc.journal.ciudad
Amsterdam
dc.description.fil
Fil: Oortwijn, Wija. Radboud Universiteit Nijmegen; Países Bajos
dc.description.fil
Fil: Husereau, Don. University of Ottawa; Canadá
dc.description.fil
Fil: Abelson, Julia. Mc Master University; Canadá
dc.description.fil
Fil: Barasa, Edwine. Wellcome Trust Research Programme; Kenia
dc.description.fil
Fil: Bayani, Diana. National University Of Singapore; Singapur
dc.description.fil
Fil: Canuto Santos, Vania. Ministerio Da Saude; Brasil
dc.description.fil
Fil: Culyer, Anthony. University of York; Reino Unido
dc.description.fil
Fil: Facey, Karen. No especifíca;
dc.description.fil
Fil: Grainger, David. Biointelect; Australia
dc.description.fil
Fil: Kieslich, Katharina. Universidad de Viena; Austria
dc.description.fil
Fil: Ollendorf, Daniel. Tufts University; Estados Unidos
dc.description.fil
Fil: Pichón-riviere, Andres. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
dc.description.fil
Fil: Sandman, Lars. Linköping University; Suecia
dc.description.fil
Fil: Strammiello, Valentina. European Patients’ Forum; Bélgica
dc.description.fil
Fil: Teerawattananon, Yot. Thailand Ministry Of Public Health; Tailandia
dc.journal.title
Value In Health
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/ark/https://www.sciencedirect.com/science/article/pii/S1098301522001607
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.jval.2022.03.018
Archivos asociados